Seven-step framework to enhance practitioner explanations and parental understandings of research without prior consent in paediatric emergency and critical care trials.


Journal

Emergency medicine journal : EMJ
ISSN: 1472-0213
Titre abrégé: Emerg Med J
Pays: England
ID NLM: 100963089

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 29 01 2020
revised: 27 05 2020
accepted: 24 06 2020
pubmed: 31 8 2020
medline: 13 7 2021
entrez: 31 8 2020
Statut: ppublish

Résumé

Alternatives to prospective informed consent enable the conduct of paediatric emergency and critical care trials. Research without prior consent (RWPC) involves practitioners approaching parents after an intervention has been given and seeking consent for their child to continue in the trial. As part of an embedded study in the 'Emergency treatment with Levetiracetam or Phenytoin in Status Epilepticus in children' (EcLiPSE) trial, we explored how practitioners described the trial and RWPC during recruitment discussions, and how well this information was understood by parents. We aimed to develop a framework to assist trial conversations in future paediatric emergency and critical care trials using RWPC. Qualitative methods embedded within the EcLiPSE trial processes, including audiorecorded practitioner-parent trial discussions and telephone interviews with parents. We analysed data using thematic analysis, drawing on the Realpe We analysed 76 recorded trial discussions and conducted 30 parent telephone interviews. For 19 parents, we had recorded trial discussion and interview data, which were matched for analysis. Parental understanding of the EcLiPSE trial was enhanced when practitioners: provided a comprehensive description of trial aims; explained the reasons for RWPC; discussed uncertainty about which intervention was best; provided a balanced description of trial intervention; provided a clear explanation about randomisation and provided an opportunity for questions. We present a seven-step framework to assist recruitment practice in trials involving RWPC. This study provides a framework to enhance recruitment practice and parental understanding in paediatric emergency and critical care trials involving RWPC. Further testing of this framework is required.

Sections du résumé

BACKGROUND BACKGROUND
Alternatives to prospective informed consent enable the conduct of paediatric emergency and critical care trials. Research without prior consent (RWPC) involves practitioners approaching parents after an intervention has been given and seeking consent for their child to continue in the trial. As part of an embedded study in the 'Emergency treatment with Levetiracetam or Phenytoin in Status Epilepticus in children' (EcLiPSE) trial, we explored how practitioners described the trial and RWPC during recruitment discussions, and how well this information was understood by parents. We aimed to develop a framework to assist trial conversations in future paediatric emergency and critical care trials using RWPC.
METHODS METHODS
Qualitative methods embedded within the EcLiPSE trial processes, including audiorecorded practitioner-parent trial discussions and telephone interviews with parents. We analysed data using thematic analysis, drawing on the Realpe
RESULTS RESULTS
We analysed 76 recorded trial discussions and conducted 30 parent telephone interviews. For 19 parents, we had recorded trial discussion and interview data, which were matched for analysis. Parental understanding of the EcLiPSE trial was enhanced when practitioners: provided a comprehensive description of trial aims; explained the reasons for RWPC; discussed uncertainty about which intervention was best; provided a balanced description of trial intervention; provided a clear explanation about randomisation and provided an opportunity for questions. We present a seven-step framework to assist recruitment practice in trials involving RWPC.
CONCLUSION CONCLUSIONS
This study provides a framework to enhance recruitment practice and parental understanding in paediatric emergency and critical care trials involving RWPC. Further testing of this framework is required.

Identifiants

pubmed: 32862140
pii: emermed-2020-209488
doi: 10.1136/emermed-2020-209488
pmc: PMC7907554
doi:

Substances chimiques

Anticonvulsants 0
Levetiracetam 44YRR34555
Phenytoin 6158TKW0C5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

198-204

Subventions

Organisme : Department of Health
ID : 12/127/134
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Clin Epidemiol. 2016 Aug;76:166-74
pubmed: 26898705
Crit Care. 2019 Mar 7;23(1):69
pubmed: 30845977
BMJ. 2002 Oct 5;325(7367):766-70
pubmed: 12364308
BMJ Open. 2015 Sep 18;5(9):e008522
pubmed: 26384724
Lancet. 2019 May 25;393(10186):2125-2134
pubmed: 31005385
Arch Dis Child. 2018 Jan;103(1):28-32
pubmed: 28847877
Trials. 2017 Jun 19;18(1):283
pubmed: 28629473
BMC Med Ethics. 2009 Feb 16;10:1
pubmed: 19220889
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Trials. 2014 Jan 06;15:5
pubmed: 24393291
Trials. 2019 Mar 21;20(1):181
pubmed: 30898169
BMJ Open. 2014 May 15;4(5):e005045
pubmed: 24833694
Arch Dis Child. 2014 Jun;99(6):602-3
pubmed: 24615624
Soc Sci Med. 2004 Jun;58(12):2445-57
pubmed: 15081196
Soc Sci Med. 2009 Jun;68(11):2018-28
pubmed: 19364625
Cochrane Database Syst Rev. 2010 Apr 14;(4):MR000013
pubmed: 20393971
Arch Dis Child Educ Pract Ed. 2016 Feb;101(1):49-53
pubmed: 26464416
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
PLoS One. 2013 Jul 03;8(7):e67352
pubmed: 23844006
PLoS One. 2011;6(7):e21604
pubmed: 21765898
BMC Med Ethics. 2013 Nov 06;14:45
pubmed: 24195717

Auteurs

Louise Roper (L)

Institute of Population Health, University of Liverpool, Liverpool, UK.

Mark D Lyttle (MD)

Emergency Department, Bristol Royal Children's Hospital, Bristol, UK.
Faculty of Health and Applied Sciences, University of the West of England, Bristol, UK.

Carrol Gamble (C)

Clinical Trials Research Centre (CTRC), University of Liverpool, Liverpool, UK.

Amy Humphreys (A)

Clinical Trials Research Centre (CTRC), University of Liverpool, Liverpool, UK.

Shrouk Messahel (S)

Emergency Department, Alder Hey Children's NHS Foundation Trust, Liverpool, Merseyside, UK.

Elizabeth D Lee (ED)

Emergency Department, Alder Hey Children's NHS Foundation Trust, Liverpool, Merseyside, UK.

Joanne Noblet (J)

Emergency Department, Alder Hey Children's NHS Foundation Trust, Liverpool, Merseyside, UK.

Helen Hickey (H)

Clinical Trials Research Centre (CTRC), University of Liverpool, Liverpool, UK.

Naomi Rainford (N)

Clinical Trials Research Centre (CTRC), University of Liverpool, Liverpool, UK.

Anand Iyer (A)

Department of Neurology, Alder Hey Children's NHS Foundation Trust, Liverpool, Merseyside, UK.

Richard Appleton (R)

Department of Neurology, Alder Hey Children's NHS Foundation Trust, Liverpool, Merseyside, UK.

Kerry Woolfall (K)

Institute of Population Health, University of Liverpool, Liverpool, UK k.woolfall@liverpool.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH